Total Synthesis of Complex Peptidyl Nucleoside Antibiotics: Asymmetric De Novo Syntheses of Miharamycin B and Its Biosynthetic Precursor

Angew Chem Int Ed Engl. 2022 Aug 1;61(31):e202204907. doi: 10.1002/anie.202204907. Epub 2022 Jun 21.

Abstract

Miharamycins belong to a class of peptidyl nucleoside antibiotics with a unique nine-carbon pyranosyl amino acid core and a rare 2-aminopurine moiety. Herein, we report the de novo total synthesis of miharamycin B and its biosynthetic precursor from 3-bromofuran and Garner's aldehyde through a modified Achmatowicz reaction. Many challenges were resolved toward the de novo synthesis of miharamycin B, including the introduction of a dense array of functional groups, the stereoselective construction of consecutive stereocenters, dealing with the variability of the anomeric positions, and promoting site-selectivity in the cyclization to form the tetrahydrofuran ring. This de novo synthesis strategy enables efficient preparation of 3'-substituted saccharides, allowing the study of their structure-activity relationships and mode of action, and meets the growing demand for the development of novel antibiotics inspired by miharamycin natural products.

Keywords: Biosynthetic Precursors; Carbohydrates; Natural Products; Nucleoside Antibiotics; Total Synthesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acids / chemistry
  • Anti-Bacterial Agents* / chemistry
  • Nucleosides* / chemistry
  • Stereoisomerism
  • Structure-Activity Relationship

Substances

  • Amino Acids
  • Anti-Bacterial Agents
  • Nucleosides
  • miharamycin B